|
|
|
Volumn 16, Issue 1, 2001, Pages 8-9
|
|
Neotrofin clinical trials show promise.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 ((3 (1,6 DIHYRO 6 OXO 9H PURIN 9 YL) 1 OXOPROPYL)AMINO)BENZOIC ACID;
4-((3-(1,6-DIHYRO-6-OXO-9H-PURIN-9-YL)-1-OXOPROPYL)AMINO)BENZOIC ACID;
AMINOBENZOIC ACID DERIVATIVE;
HYPOXANTHINE DERIVATIVE;
NOOTROPIC AGENT;
PURINE DERIVATIVE;
ALZHEIMER DISEASE;
ARTICLE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
HUMAN;
PHASE 2 CLINICAL TRIAL;
PILOT STUDY;
ALZHEIMER DISEASE;
AMINOBENZOIC ACIDS;
CLINICAL TRIALS, PHASE II;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
HUMANS;
HYPOXANTHINES;
NOOTROPIC AGENTS;
PILOT PROJECTS;
PURINES;
|
|
EID: 0035227110
PISSN: 15333175
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|